Transmission of SARS-CoV-2
Eric A. Meyerowitz, Aaron Richterman, Rajesh T. Gandhi, Paul E. Sax
Abstract
LettersJuly 2021Transmission of SARS-CoV-2FREEEric A. Meyerowitz, MD, Aaron Richterman, MD, MPH, Rajesh T. Gandhi, MD, Paul E. Sax, MDEric A. Meyerowitz, MDMontefiore Medical Center, Bronx, New York, Aaron Richterman, MD, MPHHospital of the University of Pennsylvania, Philadelphia, Pennsylvania, Rajesh T. Gandhi, MDMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, Paul E. Sax, MDHarvard Medical School and Brigham and Women's Hospital, Boston, MassachusettsAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L21-0166 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE: We agree wholeheartedly with Dr. Bilbo's comments. As we describe in our review, heterogeneity is perhaps the most important feature of the transmission dynamics of SARS-CoV-2. Among other reasons, this heterogeneity has made it difficult to estimate the reproductive number for this virus. Wide ranges have been reported in different settings, as described in a large systemic review of this topic (1).We agree that Sun and colleagues' article (2) describing the transmission dynamics in the Hunan outbreak is important and illustrative. The major findings of this study have also been replicated in other settings, as we highlighted in our review. These findings include that susceptibility to infection can be based on age (with young children approximately half as susceptible as other persons), proximity is a key determinant of transmission risk, and presymptomatic transmission plays a major role in sustaining outbreaks. We also agree that the relatively long and highly variable incubation period has substantially contributed to the difficulty with controlling the pandemic.References1. Billah MA, Miah MM, Khan MN. Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence. PLoS One. 2020;15:e0242128. [PMID: 33175914] doi:10.1371/journal.pone.0242128 CrossrefMedlineGoogle Scholar2. Sun K, Wang W, Gao L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371. [PMID: 33234698] doi:10.1126/science.abe2424 CrossrefMedlineGoogle Scholar Comments 0 Comments Sign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Eric A. Meyerowitz, MD; Aaron Richterman, MD, MPH; Rajesh T. Gandhi, MD; Paul E. Sax, MDAffiliations: Montefiore Medical Center, Bronx, New YorkHospital of the University of Pennsylvania, Philadelphia, PennsylvaniaMassachusetts General Hospital and Harvard Medical School, Boston, MassachusettsHarvard Medical School and Brigham and Women's Hospital, Boston, MassachusettsDisclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-5008. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoTransmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors Eric A. Meyerowitz , Aaron Richterman , Rajesh T. Gandhi , and Paul E. Sax Transmission of SARS-CoV-2 Boris Bikbov Metrics Cited bySpread of viruses, which measures are the most apt to control COVID-19?A patchy theoretical model for the transmission dynamics of SARS-Cov-2 with optimal controlSevere Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019–2021Single cell gene expression profiling of nasal ciliated cells reveals distinctive biological processes related to epigenetic mechanisms in patients with severe COVID-19Efficacy of washing produce in removing human coronavirus OC43 and murine norovirusCellulosic copper nanoparticles and a hydrogen peroxide–based disinfectant trigger rapid inactivation of pseudoviral particles expressing the Spike protein of SARS-CoV-2, SARS-CoV, and MERS-CoVConcordance of SARS-CoV-2 RNA in Aerosols From a Nurses Station and in Nurses and Patients During a Hospital Ward OutbreakEvaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2Outbreak of coronavirus disease 2019 (COVID-19) among operating room staff of a tertiary referral center: An epidemiologic and environmental investigationAnalysis of SARS-CoV-2 RNA Persistence across Indoor Surface Materials Reveals Best Practices for Environmental Monitoring ProgramsLess attention paid to waterborne SARS-CoV-2 spreading in Beijing urban communitiesRehabilitation for Patients with COVID-19: A Japanese Single-center ExperienceDischarge criteria for patients with COVID-19 to long-term care facilities requires modification July 2021Volume 174, Issue 7 Page: 1037 Keywords Children COVID-19 Health care providers Infants Inoculation Pulmonary diseases Respiratory system Upper respiratory tract infections Viral load Viral transmission and infection ePublished: 20 July 2021 Issue Published: July 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...